Stocktoria

CorMedix Inc. CRMD

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2010-03-25 · LEI

CorMedix Inc. statistics & valuation

Market cap$615.8M
P / E3.8×
P / S2.0×
P / B1.5×
P / FCF3.6×
Net margin52.3%
Return on equity40.2%
FCF margin55.4%
Return on capital23%
Graham number +115.8%$15.32

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($15.32); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-10996.50% -10023.40% -6242.40% -5801.30% -9207.70% -14774.70% -45409.90% -41.20% 52.30% 2016201720182019202020212022202320242025
Gross margin (%)
-63.60% 65.10% 7.70% -31.80% 14.40% 22.00% 94.30% 92.70% 88.50% 2016201720182019202020212022202320242025
Operating margin (%)
-11048.80% -9997.40% -6250.40% -7416.30% -11378.40% -15417.50% -46819.90% -51.40% 48.20% 2016201720182019202020212022202320242025
Return on equity (%)
-138.30% -458.90% -543.70% -69.50% -49.80% -44.90% -53.90% -66.10% -21.20% 40.20% 2016201720182019202020212022202320242025
Shares outstanding
40.4M 71.4M 21.8M 25.7M 33.6M 38.1M 42.8M 54.9M 64.4M 79.3M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-112.50% -245.40% -142.50% -55.80% -44.70% -40.90% -47.90% -56.50% -15.10% 19.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-9961.50% -8726.60% -5525.70% -5326.70% -9229.70% -11826.20% -37573.50% -116.70% 55.40% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.75 -$0.74 -$0.91 -$0.30 $2.04 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin88.5%92.7%—94.3%22.0%14.4%-31.8%7.7%65.1%-63.6%
Operating margin48.2%-51.4%—-46819.9%-15417.5%-11378.4%-7416.3%-6250.4%-9997.4%-11048.8%
Net margin52.3%-41.2%—-45409.9%-14774.7%-9207.7%-5801.3%-6242.4%-10023.4%-10996.5%
FCF margin55.4%-116.7%—-37573.5%-11826.2%-9229.7%-5326.7%-5525.7%-8726.6%-9961.5%
Return on assets19.7%-15.1%-56.5%-47.9%-40.9%-44.7%-55.8%-142.5%-245.4%-112.5%
Return on equity40.2%-21.2%-66.1%-53.9%-44.9%-49.8%-69.5%-543.7%-458.9%-138.3%
Current ratio2.113.396.979.4412.4411.585.042.402.125.34

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.